• Developing a novel technology platform for the safe and effective expression of immunotherapies within solid tumors

    Salspera is a clinical phase company, with a proprietary platform technology enabling the non-toxic delivery of immunotherapies into the solid tumor microenvironment. Salspera's novel therapeutic constructs act as smart, guided, micro-factories, manufacturing highly potent immunotherapies within primary tumors and metastases. Together with other effective mechanisms of action, Salspera's therapies have shown efficacy and exceptional safety in solid tumors.